Patient Square Capital LP

Q1 2025 13F Holdings

  • Location
    menlo park, CA
  • Num holdings

    19

  • Value ($000)

    $241,723

  • Date Filed
    05/14/2025
  • Form type
    13F-HR
  • CIK
    0001819257
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

ROIVANT SCIENCES LTD.

SHS
G76279101
$125.92 M
52 %

12,480,000

INSM
INSM

INSMED INC

COM PAR $.01
457669307
$25.19 M
10 %

330,250

LQDA
LQDA

LIQUIDIA CORPORATION

COM NEW
53635D202
$22.46 M
9 %

1,522,452

EYPT
EYPT

EYEPOINT PHARMACEUTICALS, INC.

COM NEW
30233G209
$8.03 M
3 %

1,481,977

OCUL
OCUL

OCULAR THERAPEUTIX, INC.

COM
67576A100
$6.75 M
3 %

920,199

CGEM
CGEM

CULLINAN THERAPEUTICS, INC.

COM
230031106
$6.65 M
3 %

878,897

NRIX
NRIX

NURIX THERAPEUTICS, INC.

COM
67080M103
$5.31 M
2 %

447,296

MIRM
MIRM

MIRUM PHARMACEUTICALS, INC.

COM
604749101
$5.24 M
2 %

116,362

ELVN
ELVN

ENLIVEN THERAPEUTICS, INC.

COM
29337E102
$5.00 M
2 %

253,838

SRRK
SRRK

SCHOLAR ROCK HOLDING CORPORATION

COM
80706P103
$4.95 M
2 %

154,000

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 19